Skip to main content
B

BONRAYBIO CO., LTD. — Investor Relations & Filings

Ticker · 6955 TW Manufacturing
Open in API
Filings indexed 12 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country TW Taiwan
Listing TW 6955

About BONRAYBIO CO., LTD.

https://www.bonraybio.com

Bonraybio Co., Ltd. specializes in providing comprehensive male infertility solutions through its proprietary LensHooke® brand. The company develops high-precision medical devices and consumables designed to enhance global reproductive healthcare. Its core product portfolio includes automated sperm quality analyzers, sperm DNA fragmentation test kits, and advanced sperm separation systems. Leveraging extensive expertise in medical equipment development, Bonraybio integrates micro-optical technology with artificial intelligence and deep learning algorithms to deliver standardized and efficient diagnostic results. The company achieved a significant milestone by securing FDA clearance for the world's first AI-powered sperm DNA fragmentation test. With a global distribution network spanning over 50 countries, Bonraybio focuses on improving clinical workflows and diagnostic accuracy in the field of male reproductive medicine.

Recent filings

Filing Released Lang Actions
115年04月內部人持股異動(事後)
Regulatory Filings
2026-05-05 Chinese
115年04月董事會成員及持股
Regulatory Filings
2026-05-05 Chinese
115年年報及股東會資料 — 2026_6955_20260520F17.pdf
Major Shareholding Notification Classification · 1% confidence The document is a regulatory disclosure listing the top ten shareholders of 邦睿生技股份有限公司 as of 115/03/31, showing each holder’s share count, percentage and relationships (spouse, related persons). This is not an annual or interim report, not a remuneration or AGM material, but a standard major shareholding schedule. It falls under “Major Shareholding Notification” (MRQ) rather than a fallback RNS.
2026-04-27 Chinese
115年年報及股東會資料 — 2025_6955_20260520FE4.pdf
Annual Report Classification · 1% confidence The document is explicitly titled '2025 Annual Report' for Bonraybio Co., Ltd. It contains comprehensive sections including a letter to shareholders, corporate governance reports, financial performance analysis, and appendices containing the consolidated and individual financial reports for the fiscal year 2025. It meets all the criteria for a full annual report. FY 2025
2026-04-27 English
115年年報及股東會資料 — 2025_6955_20260520F04.pdf
Annual Report Classification · 1% confidence The document is titled '一一四年度 年報' (2025 Annual Report) for '邦睿生技股份有限公司' (Bonraybio Co., Ltd.). It contains comprehensive sections including a letter to shareholders, corporate governance reports, financial performance analysis, and appendices containing the full audited financial statements. This structure and content align perfectly with the definition of an Annual Report (10-K). FY 2025
2026-04-27 Chinese
115年年報及股東會資料 — 2026_6955_20260520FE2.pdf
Regulatory Filings
2026-04-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.